Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Pulmonary Pharmacology & Therapeutics|June 17, 2019
Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthmaLeif Bjermer, Katharine Abbott-Banner, Kenneth Newman
Current Topics in Medicinal Chemistry|March 20, 2013
Targeting TRP channels in airway disordersKatharine Abbott-Banner, Christopher Poll, J Martin Verkuyl
The European Respiratory Journal|September 1, 2018
The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPDDave Singh, Katharine Abbott-Banner, Thomas Bengtsson, et al.
Clinical Science (London, England : 1979)|October 21, 2014
Translational models of lung diseasePaul F Mercer, Katharine Abbott-Banner, Ian M Adcock, et al.
Annals of the Rheumatic Diseases|October 17, 2024
Efficacy, safety and tolerability of GSK3858279, an anti-CCL17 monoclonal antibody and analgesic, in healthy volunteers and patients with knee osteoarthritis pain: a phase I, randomised, double-blind, placebo-controlled, proof-of-mechanism and proof-of-concept studyJagtar Singh Nijjar, Katharine Abbott-Banner, Yolanda Alvarez, et al.
Pageof 1